The DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.
Long-acting dihydropyridine calcium-channel blockers and sympathetic nervous system activity in hypertension: A literature review comparing amlodipine and nifedipine GITS
Open accessAbstract
Calcium-channel blockers (CCBs) constitute a diverse group of compounds but are often referred to as a single homogeneous class of drug and the clinical responses indiscriminately summarized. Even within the dihydropyridine subgroup, there are significant differences in formulations, pharmacokinetics, durations of action and their effects on blood pressure, heart rate, end organs and the sympathetic nervous system. Amlodipine and nifedipine in the gastrointestinal therapeutic system (GITS) formulation are the most studied of the once-daily CCBs. Amlodipine has an inherently long pharmacokinetic half-life, whereas, in contrast, nifedipine has an inherently short half-life but in the GITS formulation the sophisticated delivery system allows for once-daily dosing. This article is derived from a systematic review of the published literature in hypertensive patients. The following search terms in three main databases (MEDLINE, Embase, Science Citation Index) from 1990 to 2011 were utilized: amlodipine, nifedipine, sympathetic nervous system, sympathetic response, sympathetic nerve activity, noradrenaline, norepinephrine and heart rate. More than 1500 articles were then screened to derive the relevant analysis. As markers of sympathetic nervous system activation, studies of plasma norepinephrine concentrations, power spectral analysis, muscle sympathetic nerve activity and norepinephrine spillover were reviewed. Overall, each drug lowered blood pressure in hypertensive patients in association with only small changes in heart rate (i.e. <1 beat/min). Plasma norepinephrine concentrations, as the most widely reported marker of sympathetic nervous system activity, showed greater increases in patients treated with amlodipine than with nifedipine GITS. The evidence indicates that both these once-daily dihydropyridine CCBs lower blood pressure effectively with minimal effects on heart rate. There are small differences between the drugs in the extent to which each activates the sympathetic nervous system with an overall non-significant trend in favour of nifedipine GITS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ahmed, A., Jorna, T., & Bhandari, S. (2016) · Nephron · doi:10.1159/000447068 · Cited by 11,717
The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group (2002) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.288.23.2981 · Cited by 5,664
Pagani, M., Lombardi, F., Guzzetti, S., Rimoldi, O., Furlan, R., Pizzinelli, P., Sandrone, G., Malfatto, G., Dell'Orto, S., & Piccaluga, E. (1986) · Circulation Research · doi:10.1161/01.res.59.2.178 · Cited by 4,130
Brown, M. J., Palmer, C. R., Castaigne, A., de Leeuw, P. W., Mancia, G., Rosenthal, T., & Ruilope, L. M. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02527-7 · Cited by 1,209
Heart rate and the cardiovascular risk
Palatini, P., & Julius, S. (1997) · Journal of Hypertension · doi:10.1097/00004872-199715010-00001 · Cited by 505
(1986) · Heart · doi:10.1136/hrt.56.5.400 · Cited by 271
Nifedipine: Kinetics and dynamics in healthy subjects
Kleinbloesem, C. H., van Brummelen, P., Van De Linde, J. A., Voogd, P. J., & Breimer, D. D. (1984) · Clinical Pharmacology and Therapeutics · doi:10.1038/clpt.1984.105 · Cited by 223
Corcoran Lecture. Sympathetic hyperactivity and coronary risk in hypertension.
Julius, S. (1993) · Hypertension · doi:10.1161/01.hyp.21.6.886 · Cited by 215
Secondary prevention reinfarction Israeli nifedipine trial (SPRINT).
THE ISRAELI SPRINT STUDY GROUP (1988) · European Heart Journal · doi:10.1093/oxfordjournals.eurheartj.a062511 · Cited by 156
Effect of Calcium Antagonists on Plasma Norepinephrine Levels, Heart Rate, and Blood Pressure
Grossman, E., & Messerli, F. H. (1997) · The American Journal of Cardiology · doi:10.1016/s0002-9149(97)00722-4 · Cited by 145
Sakata, K., Shirotani, M., Yoshida, H., Nawada, R., Obayashi, K., Togi, K., & Miho, N. (1999) · Hypertension · doi:10.1161/01.hyp.33.6.1447 · Cited by 114
de Champlain, J., Karas, M. G., Nguyen, P., Cartier, P., Wistaff, R., Toal, C. B., Nadeau, R. A., & Larochelle, P. M. (1998) · Journal of Hypertension · doi:10.1097/00004872-199816090-00017 · Cited by 104
Self-citationStruck, J., Muck, P. M., Trübger, D., Handrock, R., Weidinger, G., Dendorfer, A., & Dodt, C. (2002) · Journal of Hypertension · doi:10.1097/00004872-200206000-00026 · Cited by 73
Leenen, F. H. H., & Holliwell, D. L. (1992) · The American Journal of Cardiology · doi:10.1016/0002-9149(92)90156-s · Cited by 69
Hamada, T., Watanabe, M., Kaneda, T., Ohtahara, A., Kinugawa, T., Hisatome, I., Fujimoto, Y., Yoshida, A., & Shigemasa, C. (1998) · Journal of Hypertension · doi:10.1097/00004872-199816010-00016 · Cited by 67
Karas, M. G., Lacourcière, Y., LeBlanc, A.-R., Nadeau, R. A., Dubé, B., Florescu, M., Lamarre-Cliché, M., Poirier, L., Larochelle, P. M., & de Champlain, J. (2005) · Journal of Hypertension · doi:10.1097/01.hjh.0000170389.69202.53 · Cited by 60
Fogari, R., Zoppi, A., Corradi, L., Preti, P. S., Malalamani, G. D., & Mugellini, A. (2000) · Journal of Hypertension · doi:10.1097/00004872-200018120-00023 · Cited by 57
Effects of Chronic Calcium Channel Blockade on Sympathetic Nerve Activity in Hypertension
Binggeli, C., Corti, R., Sudano, I., Lüscher, T. F., & Noll, G. (2002) · Hypertension · doi:10.1161/01.hyp.0000013264.41234.24 · Cited by 56
Fogari, R. (2003) · American Journal of Hypertension · doi:10.1016/s0895-7061(03)00901-4 · Cited by 51
Nifedipine kinetics and dynamics during rectal infusion to steady state with an osmotic system
Kleinbloesem, C. H., van Harten, J., de Leede, L. G. J., van Brummelen, P., & Breimer, D. D. (1984) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1984.194 · Cited by 48
Hemodynamic comparison of two nifedipine formulations in patients with essential hypertension
Frohlich, E. D., Loughlin, M. J. M., Losem, C. J., Ketelhut, R. G., & Messerli, F. H. (1991) · The American Journal of Cardiology · doi:10.1016/0002-9149(91)90243-e · Cited by 47
Leenen, F. H. H., & Fourney, A. (1996) · PubMed · Cited by 45
EFFECTS OF AMLODIPINE AND NIFEDIPINE RETARD ON AUTONOMIC NERVE ACTIVITY IN HYPERTENSIVE PATIENTS
Minami, J., Ishimitsu, T., Kawano, Y., & Matsuoka, H. (1998) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.1998.tb02254.x · Cited by 45
Lindqvist, M., Kahan, T., Melcher, A., Ekholm, M., & Hjemdahl, P. (2006) · Journal of Hypertension · doi:10.1097/hjh.0b013e3280104dba · Cited by 41
de Champlain, J., Karas, M. G., Assouline, L., Nadeau, R. A., LeBlanc, A.-R., Dubé, B., & Larochelle, P. M. (2007) · Journal of Clinical Hypertension · doi:10.1111/j.1524-6175.2007.05938.x · Cited by 36
The effects of nifedipine and hydralazine induced hypotension on sympathetic activity
Murphy, M. B., Scriven, A., Brown, M. J., Causon, R. C., & Dollery, C. T. (1982) · European Journal of Clinical Pharmacology · doi:10.1007/bf00637492 · Cited by 35
Leenen, F. H. H., & Fourney, A. (1996) · The American Journal of Cardiology · doi:10.1016/s0002-9149(96)90396-3 · Cited by 35
Lopez, L. M., Thorman, A. D., & Mehta, J. L. (1990) · The American Journal of Cardiology · doi:10.1016/0002-9149(90)91118-p · Cited by 31
EGUCHI, K., Kario, K., & Shimada, K. (2002) · Hypertension Research · doi:10.1291/hypres.25.329 · Cited by 28
Sympathoinhibitory and Depressor Effects of Amlodipine in Spontaneously Hypertensive Rats
Huang, B. S., & Leenen, F. H. H. (2003) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-200308000-00001 · Cited by 23
Halperin, A. K., Icenogle, M. V., Kapsner, C. O., Chick, T. W., Roehnert, J., & Murata, G. H. (1993) · American Journal of Hypertension · doi:10.1093/ajh/6.12.1025 · Cited by 23
Bilge, A. K., Atilgan, D., Tükek, T., Özcan, M., Özben, B., Koylan, N., & MeriÇ, M. (2005) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2005.00464.x · Cited by 22
Comparative Pharmacokinetics and Antihypertensive Effects of the Nifedipine Tablet and Capsule
Myers, M. G., & Rämsch, K. D. (1987) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-198706110-00029 · Cited by 22
Sasaguri, M., Matsumoto, N., Noda, K., Koga, M., Kinoshita, A., Ideishi, M., & Arakawa, K. (1997) · European Journal of Clinical Pharmacology · doi:10.1007/s002280050362 · Cited by 22
Murzenok, P. P., Huang, B. S., & Leenen, F. H. H. (2000) · Hypertension · doi:10.1161/01.hyp.35.2.631 · Cited by 22
Ruzicka, M., Coletta, E., Floras, J. S., & Leenen, F. H. H. (2004) · Journal of Hypertension · doi:10.1097/00004872-200405000-00028 · Cited by 21
Donati, L., Bühler, F. R., Beretta-Piccoli, C., Kusch, F., & Heinen, G. (1992) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1992.102 · Cited by 21
Effects of Nifedipine-GITS on Left Ventricular Mass and Left Ventricular Filling
Phillips, R. A., Ardeljan, M., Shimabukuro, S., Goldman, M. E., Garbowit, D. L., Eison, H. B., & Krakoff, L. R. (1992) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-199219002-00007 · Cited by 20
Fogari, R., Preti, P. S., Zoppi, A., Corradi, L., Pasotti, C., Rinaldi, A., & Mugellini, A. (2005) · American Journal of Hypertension · doi:10.1016/j.amjhyper.2004.11.020 · Cited by 19
Leenen, F. H. H., Myers, M. G., Joyner, C. D., & Toal, C. B. (2002) · PubMed · Cited by 18
Self-citationOhbayashi, Y., Tsutamoto, T., Sakaguchi, T., Tanaka, T., Kanamori, T., Yokohama, H., Sichiri, G., Hukai, D., Okabayashi, T., Ozawa, T., et al. (2003) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-200312001-00016 · Cited by 18
Pellizzer, A., Kamen, P. W., Esler, M., Lim, S. S., & Krum, H. (2001) · Journal of Hypertension · doi:10.1097/00004872-200102000-00015 · Cited by 17
Effect of amlodipine on hemodynamic and endocrine responses to mental stress
Spence, J. D., Munoz, C., Huff, M. W., & Tokmakjian, S. D. (2000) · American Journal of Hypertension · doi:10.1016/s0895-7061(99)00235-6 · Cited by 17
Diamond, J. A. (2001) · American Journal of Hypertension · doi:10.1016/s0895-7061(00)01267-x · Cited by 16
Contrasting effects of verapamil and amlodipine on cardiovascular stress responses in hypertension
Lefrandt, J. D., HEITMANN, J., Sevre, K., et al. (2001) · British Journal of Clinical Pharmacology · doi:10.1046/j.0306-5251.2001.01507.x · Cited by 15
Brown, M. J., & Toal, C. B. (2007) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2007.03082.x · Cited by 15
Self-citationCurry, S. H., Lopez, L. M., Lambert, C. R., Kwon, H., & Stack, R. K. (1993) · Biopharmaceutics & Drug Disposition · doi:10.1002/bdd.2510140203 · Cited by 14
Malacco, E., Piazza, S., Scandiani, L., & Zoppi, A. (2004) · Advances in Therapy · doi:10.1007/bf02850120 · Cited by 14
Siche, J. P. (2001) · American Journal of Hypertension · doi:10.1016/s0895-7061(00)01258-9 · Cited by 14
James, M. A., Rakicka, H., Panerai, R. B., & Potter, J. (1999) · Journal of Human Hypertension · doi:10.1038/sj.jhh.1000780 · Cited by 14
Toal, C. B., Meredith, P., & Elliott, H. L. (2012) · International Journal of Clinical Pharmacology and Therapeutics · doi:10.5414/cp201603 · Cited by 13
Self-citationComparative Pharmacokinetics and Antihypertensive Effects of the Nifedipine Tablet and Capsule
Myers, M. G., & Rämsch, K. D. (1987) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-198710100-00029 · Cited by 12
Leenen, F. H. H., Coletta, E., & White, R. A. (2005) · Journal of Hypertension · doi:10.1097/01.hjh.0000198032.07224.c3 · Cited by 11
Comparison of the effects of amlodipine and verapamil on autonomic activity in hypertensive patients
Şahin, İ., Koşar, F., Altunkan, Ş., & Günaydin, M. (2004) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2004.04.005 · Cited by 10
DeQuattro, V. L., & Lee, D.-P. (2008) · Cardiology · doi:10.1159/000177505 · Cited by 10
Effects of 4 weeks of amlodipine therapy on muscle sympathetic nerve activity
Calhoun, D. A. (1997) · American Journal of Hypertension · doi:10.1016/s0895-7061(97)88725-0 · Cited by 7
SYMPATHETIC OVERACTIVITY AND CORONARY RISK IN HYPERTENSION
Amerena, J. V., & Julius, S. (1997) · Fundamental and Clinical Pharmacology · doi:10.1111/j.1472-8206.1997.tb00882.x · Cited by 5
Ruzicka, M., Coletta, E., & Leenen, F. H. H. (2007) · American Journal of Hypertension · doi:10.1016/j.amjhyper.2007.05.014 · Cited by 3
AMLODIPINE BUT NOT VALSARTAN INCREASES MUSCLE SYMPATHETIC ACTIVITY IN HYPERTENSIVE SUBJECTS
Dodt, C., Struck, J., Muck, P. M., Trübger, D., Handrock, R., Weidinger, G., & Fehm, H. L. (2000) · Journal of Hypertension · doi:10.1097/00004872-200006001-00479 · Cited by 2
Research works printed but not linked: 8
- Leenen FHH, 2002, Can J Cardiol, 18, 1285
- Malamani GD, 1999, J Hypertens, 17, S134
- Ruzicka M, 2007, Am J Hypertens, 20, 1202
- Larochelle P, 2008, J Hypertens, 26, S462
- Sanjuliani AF, 2002, J Hypertens, 20, S206
- Calhoun DA, 1997, Journal of Investigative Medicine, 70
- Dodt C, 2000, Hypertens, 18, S29
- Lucini D, 1999, J Hypertens, 17, S253
Cited by
The Expanding Role of Pyridine and Dihydropyridine Scaffolds in Drug Design
Ling, Y., Hao, Z.-Y., Liang, D., Zhang, C.-L., Liu, Y.-F., & Wang, Y. (2021) · Drug Design, Development and Therapy · doi:10.2147/dddt.s329547 · Cited by 414
Laurent, S. (2017) · Pharmacological Research · doi:10.1016/j.phrs.2017.07.026 · Cited by 301
Metadata
- Authors
- Toal, C. B., Meredith, P. A., & Elliott, H. L.
- Affiliations
- University of Toronto (CA)
- University of Glasgow (GB)
- University of Strathclyde (GB)
- Corresponding author
- Toal, Corey B.
- Venue
- Blood Pressure
- Publisher
- Informa UK Limited
- Published
- 2012-07
- Volume
- 21
- Issue
- sup1
- Pages
- 3-10
- ISSN
- 0803-7051 (ISSN-L)
- 1651-1999
- PMC
- PMC3469239
- OpenAlex
- W2098125802
- Cited by
- 64
- References
- 60
- Citations by year
- 2026: 5 · 2025: 2 · 2024: 7 · 2023: 5 · 2022: 10 · 2021: 1 · 2020: 3 · 2019: 5 · 2018: 2 · 2017: 6 · 2016: 6 · 2015: 4 · 2014: 3 · 2013: 4 · 2012: 1
- FWCI
- 2.37
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Blood Pressure (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- Bayer
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Rate Variability and Autonomic Control
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart rate and cardiovascular health
- Keywords
- amlodipine, nifedipine GITS, dihydropyridine calcium channel blockers, hypertension, sympathetic activity, plasma norepinephrine, muscle sympathetic nerve activity, norepinephrine spillover, heart rate, blood pressure reduction, once-daily dosing, sustained-release formulation
- MeSH terms
- Aged, Aged, 80 and over, Antihypertensive Agents, Blood Pressure, Consensus Statements as Topic, Geriatrics, Humans, Hypertension, United States, Randomized Controlled Trials as Topic, Practice Guidelines as Topic, Stroke
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.